First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

globenewswire

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel – NEWSnet – News… as it used to be

More Press Releases

May 6, 2026

AI 2030 Launches CRAFT, The First Benchmark Connecting AI Credentials to Responsible AI Workplace Performance

May 6, 2026

Renée – AI Therapy App Introduces Emotional Pattern Recognition

May 6, 2026

ADIFF Launches Nationwide Virtual Film Series Showcasing the ArtMattan Films Catalog

May 6, 2026

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

AI 2030 Launches CRAFT, The First Benchmark Connecting AI Credentials to Responsible AI Workplace Performance

Renée – AI Therapy App Introduces Emotional Pattern Recognition

ADIFF Launches Nationwide Virtual Film Series Showcasing the ArtMattan Films Catalog

Autoliv Declares Quarterly Dividend